To include your compound in the COVID-19 Resource Center, submit it here.

Pulmonary

INDICATION: Bronchopulmonary dysplasia (BPD); acute lung injury

Patient sample, mouse and cell culture studies suggest inhibiting miR-34a could help treat

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE